Natus Medical Inc (NTUS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 348 | 42,594 | 32,361 | 19,050 | 8,538 |
| Depreciation Amortization | 6,744 | 16,879 | 12,820 | 8,396 | 4,223 |
| Income taxes - deferred | N/A | -2,437 | N/A | N/A | N/A |
| Accounts receivable | -2,366 | 19,723 | 19,299 | 7,594 | 10,266 |
| Accounts payable and accrued liabilities | -1,148 | -4,965 | -6,062 | -4,686 | -3,790 |
| Other Working Capital | -13,102 | 2,615 | 12,172 | -2,497 | 2,424 |
| Other Operating Activity | 10,800 | -1,722 | -2,088 | 5,136 | -2,279 |
| Operating Cash Flow | $1,276 | $72,687 | $68,502 | $32,993 | $19,382 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 24,935 | -34,019 | -25,429 | N/A | N/A |
| PPE Investments | -971 | -3,186 | -2,176 | -2,103 | -1,921 |
| Net Acquisitions | -141,705 | -15,849 | -15,849 | -6,150 | -5,649 |
| Purchase Sale Intangibles | N/A | -210 | -210 | -241 | 2 |
| Other Investing Activity | 0 | -210 | -210 | -241 | 2 |
| Investing Cash Flow | $-117,741 | $-53,264 | $-43,664 | $-8,494 | $-7,568 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 10,000 | 16,000 | 16,000 | 16,000 | 6,000 |
| Debt Issued | N/A | 140,000 | N/A | N/A | N/A |
| Debt Repayment | N/A | -16,000 | -16,000 | -6,000 | N/A |
| Common Stock Issued | 248 | 3,630 | 2,550 | 2,207 | 623 |
| Common Stock Repurchased | -1,308 | -19,289 | -18,257 | -16,754 | -9,063 |
| Other Financing Activity | -4,635 | -5,924 | -5,754 | -3,859 | -9,301 |
| Financing Cash Flow | $4,305 | $118,417 | $-21,461 | $-8,406 | $-11,741 |
| Exchange Rate Effect | 2,387 | -6,758 | -4,773 | -2,278 | -1,257 |
| Beginning Cash Position | 213,551 | 82,469 | 82,469 | 82,469 | 82,469 |
| End Cash Position | 103,778 | 213,551 | 81,073 | 96,284 | 81,285 |
| Net Cash Flow | $-109,773 | $131,082 | $-1,396 | $13,815 | $-1,184 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,276 | 72,687 | 68,502 | 32,993 | 19,382 |
| Capital Expenditure | -971 | -3,186 | -2,176 | -2,103 | -1,921 |
| Free Cash Flow | 305 | 69,501 | 66,326 | 30,890 | 17,461 |